ALCAM and HIV infectious disease: His research focuses on the increased sensitivity of HIV infection of CD14+CD16+ monocytes to CCL2 and the expression of CCR2, JAM-A, and ALCAM on CD14+CD16+ monocytes promote the entry of HIV-infected and uninfected CD14+CD16+ monocytes into the brain (35).